FDA's Schwetz Is Acting Commissioner: Is RU-486 New Touchstone?
This article was originally published in The Gray Sheet
Executive Summary
Acting Deputy Commissioner Bernard Schwetz, PhD, will oversee the agency following the resignation of FDA Commissioner Jane Henney, MD.
You may also be interested in...
FDA Commissioner Von Eschenbach Makes Resignation Plans Official
FDA Commissioner Andrew von Eschenbach will resign from the agency Jan. 20, which means the Obama administration needs to have an interim replacement ready to go on Inauguration Day
FDA Commissioner Von Eschenbach Makes Resignation Plans Official
FDA Commissioner Andrew von Eschenbach will resign from the agency Jan. 20, which means the Obama administration needs to have an interim replacement ready to go on Inauguration Day
Former FDA Commissioner Henney
Pharmaceutical distributor AmerisourceBergen Corp. elects Jane Henney, MD, to its nine-member board of directors. Henney currently is the senior scholar in residence at the Association of Academic Health Centers in Washington, D.C. She resigned her FDA post in January 2001 (1"The Gray Sheet" Jan. 22, 2001, p. 7)...